Previous studies have reported ADAMTS18 possessing tumor‐suppressing activities, which were reversed by promoter hypermethylation in several malignancies, including nasopharyngeal, esophageal squamous cell, hepatocellular, cervical carcinomas 8. Here, ADAMTS18 is linked to neoplasm.